Discover
EIKN
Eikon Therapeutics, Inc.
8.95
2 x 6.51
2 x 11.25
bid
ask
+
0.35
4.07%
2 @ 07:30 PM
8.95 +0.00 (0.00%)
| Ytd | -40.33% | |
| 1y | -40.33% |
8.65
day range
9.09
8.36
52 week range
16.26
| Open | 8.70 | Prev Close | 8.60 | Low | 8.65 | High | 9.09 | Mkt Cap | 484.78M |
| Vol | 2.24M | Avg Vol | 481.75K | EPS | -5.95 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 10.20 | 200-d Avg | 11.03 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 93.39M | ||
| Research and Development Expense | 75.46M | ||
| Selling, General and Administrative Expense | 17.93M | ||
| Operating Income | -93.39M | ||
| Interest Expense | -5.04M | ||
| Net Income | -88.41M | ||
| Net Income Common Stock | -88.41M | ||
| Net Income Common Stock (USD) | -88.41M | ||
| Consolidated Income | -88.41M | ||
| Earnings per Basic Share | -1.63 | ||
| Earnings per Basic Share (USD) | -1.63 | ||
| Earnings per Diluted Share | -1.63 | ||
| Earning Before Interest & Taxes (EBIT) | -93.45M | ||
| Earning Before Interest & Taxes (USD) | -93.45M | ||
| Weighted Average Shares | 54.14M | ||
| Weighted Average Shares Diluted | 54.14M | ||
| Balance Sheet | |||
| Cash and Equivalents | 143.01M | ||
| Cash and Equivalents (USD) | 143.01M | ||
| Investments | 396.41M | ||
| Investments Current | 388.57M | ||
| Investments Non-Current | 7.85M | ||
| Current Assets | 546.98M | ||
| Property, Plant & Equipment Net | 224.21M | ||
| Total Assets | 779.57M | ||
| Debt Current | 9.45M | ||
| Total Debt | 252.22M | ||
| Current Liabilities | 55.30M | ||
| Debt Non-Current | 242.77M | ||
| Total Liabilities | 313.07M | ||
| Accumulated Retained Earnings (Deficit) | -1.09B | ||
| Shareholders Equity | 466.50M | ||
| Shareholders Equity (USD) | 466.50M | ||
| Assets Non-Current | 232.59M | ||
| Total Debt (USD) | 252.22M | ||
| Liabilities Non-Current | 257.77M | ||
| Trade and Non-Trade Payables | 6.56M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.06M | ||
| Net Cash Flow from Financing | 25.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -18.50M | ||
| Capital Expenditure | -251.00K | ||
| Issuance (Purchase) of Equity Shares | 25.00K | ||
| Net Cash Flow from Investing | 46.43M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 46.68M | ||
| Net Cash Flow from Operations | -64.96M | ||
| Share Based Compensation | 4.22M | ||